Insmed (INSM) Income towards Parent Company (2010 - 2026)

Insmed's Income towards Parent Company history runs 17 years deep, the most recent figure standing at -$163.6 million for Q1 2026.

• On a quarterly basis, Income towards Parent Company rose 36.24% year-over-year to -$163.6 million in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 16.82% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 39.72% from the prior year.
• Income towards Parent Company grew to -$163.6 million in Q1 2026 per INSM's latest filing, from -$328.4 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$94.6 million in Q1 2022 and bottomed at -$370.0 million in Q3 2025.
• The 5-year median for Income towards Parent Company is -$186.1 million (2023), against an average of -$210.9 million.
• Across the five-year window, Income towards Parent Company tumbled 155.92% in 2023 and jumped 36.24% in 2026, its largest moves.
• Year by year, Income towards Parent Company stood at -$160.1 million in 2022, then decreased by 16.2% to -$186.1 million in 2023, then declined by 26.62% to -$235.6 million in 2024, then plunged by 39.41% to -$328.4 million in 2025, then soared by 50.19% to -$163.6 million in 2026.
• Per Business Quant, the three latest INSM Income towards Parent Company figures stand at -$163.6 million (Q1 2026), -$328.4 million (Q4 2025), and -$370.0 million (Q3 2025).